Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.

Transpl Immunol. 2006 Jan;15(3):223-7. Epub 2005 Nov 28.

PMID:
16431290
3.

Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.

Toren A, Novick D, Or R, Ackerstein A, Slavin S, Nagler A.

Transplantation. 1996 Jul 15;62(1):138-42.

PMID:
8693533
4.

Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease.

Kami M, Matsumura T, Tanaka Y, Mikami Y, Miyakoshi S, Ueyama J, Morinaga S, Mori S, Machida U, Kanda Y, Chiba S, Sakamaki H, Hirai H, Muto Y.

Leuk Lymphoma. 2000 Aug;38(5-6):533-40.

PMID:
10953974
5.
6.

Serum cytokine levels after HLA-identical bone marrow transplantation.

Liem LM, van Houwelingen HC, Goulmy E.

Transplantation. 1998 Oct 15;66(7):863-71.

PMID:
9798695
8.

Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.

Kobayashi S, Imamura M, Hashino S, Tanaka J, Asaka M.

Leuk Lymphoma. 1997 Dec;28(1-2):159-69.

PMID:
9498715
9.

Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.

Miyamoto T, Akashi K, Hayashi S, Gondo H, Murakawa M, Tanimoto K, Harada M, Niho Y.

Bone Marrow Transplant. 1996 Feb;17(2):185-90.

PMID:
8640164
10.

Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.

Foley R, Couban S, Walker I, Greene K, Chen CS, Messner H, Gauldie J.

Bone Marrow Transplant. 1998 Apr;21(8):769-73.

11.

Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.

Visentainer JE, Lieber SR, Persoli LB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA.

Exp Hematol. 2003 Nov;31(11):1044-50.

PMID:
14585368
12.
14.

Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation.

Fujimori Y, Takatsuka H, Takemoto Y, Hara H, Okamura H, Nakanishi K, Kakishita E.

Br J Haematol. 2000 Jun;109(3):652-7.

PMID:
10886219
15.

Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation.

Mathias C, Mick R, Grupp S, Duffy K, Harris F, Laport G, Stadtmauer E, Luger S, Schuster S, Wasik MA, Porter DL.

J Hematother Stem Cell Res. 2000 Jun;9(3):393-400.

PMID:
10894361
16.

Possible role of granulocyte colony-stimulating factor in increased serum soluble interleukin-2 receptor-alpha levels after allogeneic bone marrow transplantation.

Kobayashi S, Imamura M, Hashino S, Noto S, Mori A, Tanaka J, Naohara T, Kasai M, Asaka M.

Leuk Lymphoma. 1999 May;33(5-6):559-66.

PMID:
10342583
17.

Cell surface markers and circulating cytokines in graft versus host disease.

Chang DM, Wang CJ, Kuo SY, Lai JH.

Immunol Invest. 1999 Jan;28(1):77-86.

PMID:
10073684
18.

Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.

Bay JO, Dhédin N, Goerner M, Vannier JP, Marie-Cardine A, Stamatoullas A, Jouet JP, Yakoub-Agha I, Tabrizi R, Faucher C, Diez-Martin JL, Nunez G, Parody R, Milpied N, Espérou H, Garban F, Galambrun C, Kwiatkovski F, Darlavoix I, Zinaï A, Fischer A, Michallet M, Vernant JP.

Transplantation. 2005 Sep 27;80(6):782-8.

PMID:
16210965
19.
20.

Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment.

Tiberghien P, Racadot E, Lioure B, Delain M, Girard A, Wijdenes J, Plouvier E, Flesch M, Cahn JY, Herve P.

Transplantation. 1991 Sep;52(3):475-80.

PMID:
1910217

Supplemental Content

Support Center